Kuros Biosciences AG (SWX:KURN)
Switzerland · Delayed Price · Currency is CHF 27.46
+0.88 (3.31%)
Aug 14, 2025, 5:31 PM CET
Kuros Biosciences AG Market Cap
Kuros Biosciences AG has a market cap or net worth of 1.05 billion as of August 14, 2025. Its market cap has increased by 120.35% in one year.
Market Cap
1.05B
Enterprise Value
1.04B
Revenue
103.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
27.46
Market Cap Chart
Since January 21, 2016, Kuros Biosciences AG's market cap has decreased from 3.25B to 1.05B, a decrease of -67.58%. That is a compound annual growth rate of -11.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 1.05B | 30.79% |
| Dec 30, 2024 | 805.64M | 527.99% |
| Dec 29, 2023 | 128.29M | 138.81% |
| Dec 30, 2022 | 53.72M | -14.90% |
| Dec 30, 2021 | 63.13M | -4.70% |
| Dec 30, 2020 | 66.24M | 20.42% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jan 21, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 211.38B |
| Novartis AG | 186.29B |
| Lonza Group AG | 38.23B |
| Alcon | 34.30B |
| Galderma Group AG | 31.53B |
| Sandoz Group AG | 20.26B |
| Straumann Holding AG | 16.02B |
| Sonova Holding AG | 13.47B |